SeekInClarity Offers Promise in Monitoring Cancer Treatment Response
A new prospective study in BMC Cancer shows that the blood-based multi-omics test SeekInClarity accurately predicts treatment outcomes.
A new prospective study in BMC Cancer shows that the blood-based multi-omics test SeekInClarity accurately predicts treatment outcomes.
While the emergency department (ED) and ICU have a high rate of sample hemolysis, the NICU is vulnerable to this preanalytical error.
Amsbio has launched Collagenase and Neutral Protease NB enzymes to support high-purity, regulatory-compliant tissue dissociation workflows.
Bio-Rad Laboratories will showcase its latest clinical diagnostic solutions and host a QC workflow optimization workshop at ADLM 2025.
Researchers have developed a handheld TB test that accurately detects tuberculosis in HIV-positive individuals using a single drop of blood.